Verlaging van LDL-cholesterol: hoe lager hoe beter?

Michiel L. Bots

Verlaging van LDL-cholesterol: hoe lager hoe beter?

Translated title of the contribution: Lowering LDL-cholesterol: The lower the better?

Michiel L. Bots^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

There is still a debate about the optimal LDL level to achieve with pharmacological treatment. Some support the 'the lower, the better' approach, others support 'a level less than 2.5 mmol/l suffices'. Two recent JAMA papers lend support to both views. So what to believe? The issue is whether those with an achieved low LDL level (

Translated title of the contribution	Lowering LDL-cholesterol: The lower the better?
Original language	Dutch
Article number	D1325
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	161
Issue number	6
Publication status	Published - 1 Mar 2017

Access to Document

verlagingFinal published version, 263 KBLicence: Taverne

Cite this

@article{3e836879abc744858a9f73b4b6f60091,

title = "Verlaging van LDL-cholesterol: hoe lager hoe beter?",

abstract = "There is still a debate about the optimal LDL level to achieve with pharmacological treatment. Some support the 'the lower, the better' approach, others support 'a level less than 2.5 mmol/l suffices'. Two recent JAMA papers lend support to both views. So what to believe? The issue is whether those with an achieved low LDL level (",

author = "Bots, \{Michiel L.\}",

year = "2017",

month = mar,

day = "1",

language = "Dutch",

volume = "161",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Vereniging Nederlands Tijdschrift voor Geneeskunde",

number = "6",

}

TY - JOUR

T1 - Verlaging van LDL-cholesterol

T2 - hoe lager hoe beter?

AU - Bots, Michiel L.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - There is still a debate about the optimal LDL level to achieve with pharmacological treatment. Some support the 'the lower, the better' approach, others support 'a level less than 2.5 mmol/l suffices'. Two recent JAMA papers lend support to both views. So what to believe? The issue is whether those with an achieved low LDL level (

AB - There is still a debate about the optimal LDL level to achieve with pharmacological treatment. Some support the 'the lower, the better' approach, others support 'a level less than 2.5 mmol/l suffices'. Two recent JAMA papers lend support to both views. So what to believe? The issue is whether those with an achieved low LDL level (

UR - https://www.scopus.com/pages/publications/85014076783

M3 - Article

AN - SCOPUS:85014076783

SN - 0028-2162

VL - 161

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 6

M1 - D1325

ER -

Verlaging van LDL-cholesterol: hoe lager hoe beter?

Abstract

Access to Document

Other files and links

Fingerprint

Cite this